Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine

NCT05846373 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Migraine Prophylaxis

Interventions

DRUG: Nicotinic Acid 500 MG Extended Release Oral Tablet
DRUG: Nicotinic Acid 1000 MG Extended Release Oral Tablet
OTHER: Placebo

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh